So now that GvHD hasn't been approved surely that will have a negative consequence on OCC?
It's hard to know what has been going on behind the scenes in MSB and their ongoing communication with FDA over the past few years, however I do believe that big US pharma's have a massive influence on FDA approvals and it is very hard for small overseas standalone companies such as OCC and PAR to get approvals without a JV partner.
Media thread, page-290
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.92M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 41.5¢ | 41.0¢ | $58.47K | 142.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 54631 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 21292 | 2 |
View Market Depth
| Last trade - 11.59am 02/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |